InvestSMART

Miro Sciences Ltd (ASX: MSX) - Share Price

- Current share price for MSX : $0.053

Miro Sciences Ltd (MSX, formerly Neuroscientific Biopharmaceuticals Ltd) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is focused on the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases.

MSX General Information +

ASX Code MSX
Website http://www.neuroscientific.com
Industry/Sector Biotechnology
Market Cap ($M) 20
MSX Share Price $0.053
Day High $0.053
Day Low $0.050
Last Close $0.053
MSX Share Price Movement - ( No change )
Prices as at 11:05, 30 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Miro Sciences Ltd (MSX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Special Scrip 23¢ 80% 10 Sep 2003 17 Sep 2003 - - -

See all dividends from Miro Sciences Ltd (MSX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Miro Sciences Ltd (MSX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Name Change to Miro Sciences (MSX) 28 Oct 2026 9:17AM $2.300 $0.053 fallen by 97.70%
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Suspension from Official Quotation 29 Jun 2007 10:44AM $2.300 $0.053 fallen by 97.70%
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Court Approval of Restructure 27 Jun 2007 4:05PM $2.300 $0.053 fallen by 97.70%
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Court Approves Shareholder and Optionholder Meetings 18 May 2007 10:26AM $1.910 $0.053 fallen by 97.23%
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Trading Halt 18 May 2007 9:57AM $1.910 $0.053 fallen by 97.23%
Miro Sciences Ltd (MSX)
ORDINARY FULLY PAID
 Health Care $21 Proposed Corp Restructure & Merger with Scarborough 13 Apr 2007 4:39PM n/a $0.053 n/a

MSX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$4.48 -$1.30 5.60% 0.00 0.00 0.00% 0.0%
2025A -$1.85 -$1.30 -672.70% 0.00 0.00 0.00% 0.0%
2024A $0.32 $0.20 -129.70% 27.70 0.00 0.00% 0.0%

MSX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
CSL Limited (CSL) $94,585M 0.7309 -0.4389 0.0602 12.2108 21.7634 20.5280 2.16% 2.16% 2.23%
Mesoblast Limited (MSB) $2,446M -0.4501 0.0000 0.0000 0.0000 0.0000 854.5455 0.00% 0.00% 0.00%
Miro Sciences Ltd (MSX) $21M 0.0556 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
PYC Therapeutics Limited (PYC) $1,939M -0.3971 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Telix Pharmaceuticals Limited (TLX) $4,445M -1.3893 0.0000 -0.5235 0.0000 153.6471 322.4691 0.00% 0.00% 0.00%

MSX Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.39 0.00
Market 0.30 13.20 1.03 0.74
Sector 0.77 35.90 2.28 2.13

MSX Directors

Name Position Start Date
Mr Robert Leslie McKenzie Non-Executive Chairman, Non-Executive Director 26 Jun 2025
Mr Paul Damien John Fry Non-Executive Director 26 Jun 2025
Dr Anton Uvarov Non-Executive Director 6 Sep 2017
Mr Clarke Barlow Non-Executive Director 17 Nov 2023
Dr Linda Friedland Non-Executive Director 18 Oct 2023

Miro Sciences Ltd (MSX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Jun 2025 UVAROV, Anton Issued Options 1,000,000 $0.000 $100.000
27 Jun 2025 BARLOW, Clarke Issued Options 1,000,000 $0.000 $100.000
27 Jun 2025 UVAROV, Anton Issued Direct Shares 2,650,000 $0.035 $92,750.000

See all changes in directors' interest & trades for Miro Sciences Ltd (MSX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MSX Management

Name Position
Christopher (Chris) Bryan Achurch Company Secretary
Catherine Cole Other Corporate Officer
Marian Sturm Other Corporate Officer

MSX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Miro Sciences Ltd (MSX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
41,320,713 (10.60%) Stum West Pty Ltd
22,471,602 (5.77%) Mr Paul Damien John Fry

MSX Calendar of Events

Date Event
24 August 2027 Report (Annual)
24 August 2027 Report (Prelim)
24 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.